Literature DB >> 11893661

Overexpression of matrix metalloproteinase-7 in pulmonary fibrosis.

Gregory P Cosgrove1, Marvin I Schwarz, Mark W Geraci, Kevin K Brown, G Scott Worthen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11893661

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  11 in total

Review 1.  Gene expression profiling as a window into idiopathic pulmonary fibrosis pathogenesis: can we identify the right target genes?

Authors:  Naftali Kaminski; Ivan O Rosas
Journal:  Proc Am Thorac Soc       Date:  2006-06

Review 2.  Towards systems biology of human pulmonary fibrosis.

Authors:  Sean M Studer; Naftali Kaminski
Journal:  Proc Am Thorac Soc       Date:  2007-01

3.  Human lung project: evaluating variance of gene expression in the human lung.

Authors:  Michael P Gruber; Christopher D Coldren; Malcolm D Woolum; Gregory P Cosgrove; Chan Zeng; Anna E Barón; Mark D Moore; Carlyne D Cool; G Scott Worthen; Kevin K Brown; Mark W Geraci
Journal:  Am J Respir Cell Mol Biol       Date:  2006-02-23       Impact factor: 6.914

4.  Matrilysin (matrix metalloproteinase-7) mediates E-cadherin ectodomain shedding in injured lung epithelium.

Authors:  John K McGuire; Qinglang Li; William C Parks
Journal:  Am J Pathol       Date:  2003-06       Impact factor: 4.307

5.  MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis.

Authors:  Ivan O Rosas; Thomas J Richards; Kazuhisa Konishi; Yingze Zhang; Kevin Gibson; Anna E Lokshin; Kathleen O Lindell; Jose Cisneros; Sandra D Macdonald; Annie Pardo; Frank Sciurba; James Dauber; Moises Selman; Bernadette R Gochuico; Naftali Kaminski
Journal:  PLoS Med       Date:  2008-04-29       Impact factor: 11.069

Review 6.  Impact of Transcriptomics on Our Understanding of Pulmonary Fibrosis.

Authors:  Milica Vukmirovic; Naftali Kaminski
Journal:  Front Med (Lausanne)       Date:  2018-04-04

7.  Matrix Metalloproteinases Retain Soluble FasL-mediated Resistance to Cell Death in Fibrotic-Lung Myofibroblasts.

Authors:  David Nareznoi; Jenya Konikov-Rozenman; Dmytro Petukhov; Raphael Breuer; Shulamit B Wallach-Dayan
Journal:  Cells       Date:  2020-02-11       Impact factor: 6.600

Review 8.  Molecular biomarkers in interstitial lung diseases.

Authors:  Angelo De Lauretis; Elisabetta A Renzoni
Journal:  Mol Diagn Ther       Date:  2014-10       Impact factor: 4.074

9.  Treatment with chondroitinase ABC alleviates bleomycin-induced pulmonary fibrosis.

Authors:  Yoshiro Kai; Hiroyuki Yoneyama; Jun Koyama; Kaoru Hamada; Hiroshi Kimura; Kouji Matsushima
Journal:  Med Mol Morphol       Date:  2007-09-18       Impact factor: 2.070

10.  A blood test for lung fibrosis.

Authors:  Peter J Barnes
Journal:  PLoS Med       Date:  2008-04-29       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.